Balancing transition and readmission: a comparative study of low-dose vs standard buprenorphine initiation for medically managed opioid withdrawal. | Synapse
The study aims to compare the effectiveness of low-dose and standard-dose buprenorphine for opioid withdrawal management.
Comparative analysis of two treatment regimens: low-dose buprenorphine initiation (LDI) and standard-dose buprenorphine initiation (SDI).
Assessment of readmission rates and other clinical outcomes over a one-year period.
Focus on patients undergoing medically managed opioid withdrawal.
Both LDI and SDI produced comparable outcomes on most measures.
LDI was associated with fewer readmissions over one year, indicating a favorable impact on treatment stability.
Resumen
LDI and SDI produced comparable outcomes across most measures, with LDI associated with fewer readmissions over one year. Both approaches appear to be viable strategies in the fentanyl era.